Macrolide and Clindamycin Resistance inStreptococcus milleriGroup Isolates from the Airways of Cystic Fibrosis Patients
- 1 July 2010
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 54 (7) , 2823-2829
Abstract
Organisms belonging to theStreptococcus millerigroup (SMG) are known for their role in pyogenic infections but have recently been implicated as etiological agents of pulmonary exacerbation in adult patients with cystic fibrosis (CF). The prolonged exposure of CF patients to antibiotics prompted us to investigate the susceptibility profiles of 118 SMG isolates from the airways of CF patients to 12 antibiotics compared to 43 SMG isolates from patients with invasive infections. We found that ∼60% of all isolates failed to grow using the standard medium for disc diffusion, Mueller-Hinton blood agar (MHBA), so we explored the usefulness of brain heart infusion (BHI) agar for susceptibility testing. Zone-of-inhibition comparisons between BHI and MHBA showed strong correlations for six antibiotics, and interpretations were similar for both medium types. For ceftriaxone and cefepime, both groups of isolates were highly susceptible. Tetracycline resistance levels were comparable between the two groups (22% in CF isolates and 17.4% in invasive isolates). However, more than half of the CF isolates were not susceptible to azithromycin, erythromycin, and clindamycin, compared to 11%, 13%, and 6.5% of invasive isolates, respectively. There were 5-fold and 8-fold increased risks of azithromycin and clindamycin resistance, respectively, for the isolates from the airways of CF patients relative to the invasive isolates. Macrolide resistance was strongly linked to chronic azithromycin therapy in CF patients. This study shows that BHI agar is a suitable alternative for antimicrobial susceptibility testing for the SMG and that SMG isolates from the airways of CF patients are more resistant to macrolides and clindamycin than strains isolated from patients with invasive infections.Keywords
This publication has 51 references indexed in Scilit:
- Characterization ofStreptococcus milleriGroup Isolates from Expectorated Sputum of Adult Patients with Cystic FibrosisJournal of Clinical Microbiology, 2010
- Prevalence of erythromycin and clindamycin resistance among clinical isolates of the Streptococcus anginosus group in GermanyJournal of Medical Microbiology, 2009
- A polymicrobial perspective of pulmonary infections exposes an enigmatic pathogen in cystic fibrosis patientsProceedings of the National Academy of Sciences, 2008
- The Streptococcus milleri group—An unrecognized cause of disease in cystic fibrosis: A case series and literature reviewPediatric Pulmonology, 2008
- Molecular identification of bacteria in bronchoalveolar lavage fluid from children with cystic fibrosisProceedings of the National Academy of Sciences, 2007
- Retrospective analysis of 49 cases of brain abscess and review of the literatureEuropean Journal of Clinical Microbiology & Infectious Diseases, 2006
- Systematic review of antistaphylococcal antibiotic therapy in cystic fibrosisThorax, 2000
- Prospective Study of Streptococcus milleri Hepatic AbscessEuropean Journal of Clinical Microbiology & Infectious Diseases, 1998
- Prospective study ofStreptococcus milleri hepatic abscessEuropean Journal of Clinical Microbiology & Infectious Diseases, 1998
- Bacteriologic characteristics and antimicrobial susceptibility of 70 clinically significant isolates of Streptococcus milleri groupDiagnostic Microbiology and Infectious Disease, 1994